Tizanidine-1 (Tizanidine 1)
Tizanidine Tablet
Product Images NDC 71335-1016
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 71335-1016). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Tizanidine-2 (Tizanidine 2)
Not available. The text appears to be a mix of incomplete and unrelated information, including medication names and dosages, time intervals, and possibly other numerical codes.*
Tizanidine-3 (Tizanidine 3)
Tizanidine-4 (Tizanidine 4)
This document presents results related to the improvement in Ashworth Score. It references a mean dose of 26.8 mg and shows data collected during a study that occurred over a period of 7 weeks. The results are presented for the End of Titration and End of Maintenance stages, as well as the Endpoint based on the Last Observation Carried Forward.*
Label Image (Lbl713351016)
This text appears to be a label for a medication package. It contains information about the manufacturer, storage instructions, dosage strength and quantity, and potential side effects of the medication. The medication seems to be Zanaflex 4mg Tablet which may cause dizziness or drowsiness. The label also includes the National Drug Code (NDC) and expiration date.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
